# Impact of the New Generation Anti-diabetic Drugs on Diabetic Retinopathy

> **NCT07351786** · — · RECRUITING · sponsor: **Sara A Belal** · enrollment: 70 (estimated)

## Conditions studied

- Diabetes (DM)
- Retinopathy, Diabetic
- Diabetic Retinopathy (DR)
- Diabetic Retinopathy Associated With Type 2 Diabetes Mellitus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07351786
- **Lead sponsor:** Sara A Belal
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-09
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07351786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07351786, "Impact of the New Generation Anti-diabetic Drugs on Diabetic Retinopathy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07351786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*